AJOVY® (fremanezumab-vfrm) injection
Here you’ll find what makes AJOVY different-including info on efficacy, side effects, post hoc analyses data, dosing and administration. These videos can help healthcare providers learn about AJOVY, indicated for the preventive treatment of migraine in adults.IMPORTANT SAFETY INFORMATION
Contraindications: AJOVY is contraindicated in patients with serious hypersensitivity to fremanezumab-vfrm or to any of the excipients. Reactions have included anaphylaxis and angioedema.
Hypersensitivity Reactions: Hypersensitivity reactions, including rash, pruritus, drug hypersensitivity, and urticaria were reported with AJOVY in clinical trials.
Adverse Reactions: The most common adverse reactions in clinical trials (≥5% and greater than placebo) were injection site reactions.
See full Important Safety Information & full Prescribing Information below in links section.
©2022 Teva Pharmaceuticals USA, Inc. 11/2022
- 2:18
- Жыл бұрын
Jill Testimonial Video - Doctor Discussion
- 6:15
- Жыл бұрын
The Expert Series: Long-acting protection against migraine with AJOVY with Dr. Brad Torphy
- 8:56
- Жыл бұрын
The Expert Series: Sustained efficacy with no evidence of wearing off with Dr Jessica Ailani
- 1:06
- 2 жыл бұрын
Пікірлер